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Activation of nuclear factor-kB (NF-kB), a key medi-
ator of inducible transcription in immunity, requires
binding of NF-kB essential modulator (NEMO) to
ubiquitinated substrates. Here, we report that the
UBAN (ubiquitin binding in ABIN and NEMO) motif
of NEMOselectively binds linear (head-to-tail) ubiqui-
tin chains. Crystal structures of the UBAN motif
revealedaparallel coiled-coil dimer that formedahet-
erotetrameric complex with two linear diubiquitin
molecules. The UBAN dimer contacted all four ubiq-
uitin moieties, and the integrity of each binding site
was required for efficient NF-kB activation. Binding
occurred via a surface on the proximal ubiquitin
moiety and the canonical Ile44 surface on the distal
one, thereby providing specificity for linear chain
recognition. Residues of NEMO involved in binding
linear ubiquitin chains are required for NF-kB activa-
tion by TNF-a and other agonists, providing an expla-
nation for the detrimental effect of NEMO mutations
in patients suffering from X-linked ectodermal
dysplasia and immunodeficiency.
INTRODUCTION
Nuclear factor-kB (NF-kB), a dimeric transcription factor formed
by members of the Rel family of proteins, plays essential roles in
regulating gene expression during development, skin homeo-
stasis, and immunity. The activity of NF-kB proteins is regulated
by a variety of external stimuli, including bacterial lipopolysac-
charide (LPS), tumor necrosis factor-a (TNF-a) and interleukin-
1 (IL-1) (Hayden and Ghosh, 2008). In the canonical pathway,1098 Cell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc.NF-kB factors are retained in an inactive state by binding to
the inhibitor of NF-kB (IkB), which in response to cell stimulation
is ubiquitinated and degraded by the proteasome. Prior to its
ubiquitination, IkB is phosphorylated by the IkB kinase (IKK)
complex. The IKK complex, consisting of two kinases, IKKa
and IKKb, and the regulatory component NEMO (also known
as IKKg), is activated by an upstream kinase known as TAK1,
which is in turn activated after TNF-a or IL-1 receptor stimulation
(Ha¨cker and Karin, 2006). Receptor-proximal events appear to
initiate a specific type of ubiquitin signal, consisting of Lys63-
linked ubiquitin polymers (Hayden and Ghosh, 2008). Attach-
ment of Lys63-linked ubiquitin chains to receptor substrates
such as RIP1 (receptor-interacting protein 1, upon TNF-a stimu-
lation), IRAKs (IL-1 receptor-associated kinases, upon IL-1 stim-
ulation), or TRAFs (tumor necrosis factor receptor-associated
factors) is critical for activation of NF-kB (Ordureau et al., 2008;
Kanayama et al., 2004), a process that is catalyzed by the
Lys63-specific E2 complex Ubc13-Uev1a together with a set
of E3 ligases, including TRAFs, IAPs (inhibitors of apoptosis),
and Pellino (Deng et al., 2000; Ordureau et al., 2008; Varfolomeev
et al., 2008). However, the surprising report that Ubc13-deficient
mice elicit normal NF-kB activation in response to multiple
stimuli (Yamamoto et al., 2006) has led to speculations that addi-
tional E2s could also participate in Lys63 chain production in vivo
together with TRAF/IAP ligases. Alternatively, other types of
ubiquitin chains could mediate activation of the NF-kB pathway.
In agreement with the latter hypothesis, an E3 ligase complex,
LUBAC (linear ubiquitin chain assembly complex), was recently
shown to regulate the canonical NF-kB pathway independently
of Lys63 chains (Kirisako et al., 2006; Tokunaga et al., 2009).
Yet, it is mechanistically unclear how two differently linked ubiq-
uitin polymers, Lys63 and linear ubiquitin chains, can mediate
activation of the IKK complex.
On the basis of the correlative evidence between linkage spec-
ificity and cellular functions, it is believed that distinct ubiquitin
binding domains (UBDs) might influence the interpretation of
ubiquitin signals within cells (Hurley et al., 2006; Ikeda and Dikic,
2008). In the NF-kB pathway, available biochemical and genetic
evidence favors a model in which the adaptor proteins TAB2/3
(TAK1 binding protein 2/3) bind to Lys63-conjugated substrates,
resulting in activation of IKKa/b by its upstream kinase TAK1
(Hayden and Ghosh, 2008). Interestingly, several groups have
identified a ubiquitin binding domain in NEMO, referred to as
NUB (NEMO ubiquitin binding), CoZi (coil-zipper domain), or
UBAN (ubiquitin binding in ABIN and NEMO proteins) (hereafter
referred to as UBAN), which was thought to specifically bind to
Lys63-ubiquitinated substrates (Wu et al., 2006; Ea et al.,
2006; Bloor et al., 2008; Wagner et al., 2008). Recently, Lo
et al. solved a structure of the NEMO UBAN region and deter-
mined that NEMO binds significantly stronger to linear diubiqui-
tin as compared to Lys63-linked chains (Lo et al., 2009). Yet,
detailed information how NEMO might distinguish linear from
Lys63-linked chains and the importance of this binding event
for signaling has been lacking. Here, we provide structural and
functional evidence that the UBAN motif of NEMO binds to linear
ubiquitin chains, and that this interaction plays a crucial role in
TNF-a-induced activation of the IKK complex and NF-kB, but
not MAPK pathways in vivo.
Figure 1. The UBAN Motif of NEMO Binds to Linear
Ubiquitin Chains
(A) Bindings of diubiquitin molecules (linear diUb, Lys63-linked
diUb, or Lys48-linked diUb) to GST (cont), GST-NEMO
CoZi region (NEMO 250–339), GST-ABIN1-UBAN motif
(ABIN1 465–520), GST-Poli-UBM, GST-hRad23A-UBA, or
GST-HDAC6-NZF containing C terminus (HDAC6-Cterm)
were determined by immunoblotting with an anti-ubiquitin
antibody. Loading of GST fusion proteins was determined by
Ponceau S staining.
(B) Surface plasmon resonance data of the interaction between
NEMO and diubiquitin. GST-fused NEMO (250–339) was
immobilized on a GST antibody-coated CM5 chip. The linear
(circle), K63-linked (square), or K48-linked (triangle) diubiquitin
molecules were loaded over the chip. Each measurement was
performed at the indicated concentrations, and the fitted
curves and calculated KD values are shown.
RESULTS
UBAN Motifs Bind Selectively to Linear
Diubiquitin
Several groups have previously shown that the
coiled-coil 2 (CC2) and leucine zipper (LZ) region
(abbreviated as CoZi region) is the fragment in
NEMO necessary for binding to ubiquitin chains
(Ea et al., 2006; Wu et al., 2006; Bloor et al.,
2008). The CoZi region contains the centrally
located UBAN motif (Figure S1A available online),
a conserved domain also present in other ubiquitin
binding proteins including the ABINs and opti-
neurin (Zhu et al., 2007; Bloor et al., 2008; Wagner
et al., 2008). This fragment was further used to
assess NEMO binding to different types of ubiquitin
chains in vitro. After confirming that the UBAN motif
binds to linear, i.e., head-to-tail linked, tetraubiquitin constructs
used in previous studies (Bloor et al., 2008; Wagner et al., 2008),
we next compared its ability to interact with different diubiquitin
molecules. Interestingly, we found that the UBAN motif could
bind linear diubiquitin, but failed to interact with diubiquitin mole-
cules linked via Lys48 or Lys63 obtained from two independent
sources (Figures 1A, S1B, and S1C). Similar results were
acquired for the UBAN motif of ABIN1 (Figure 1A). These obser-
vations are clearly distinct from the NZF domain of HDAC6
(Boyault et al., 2006), the UBM of Poli (Bienko et al., 2005), and
the UBA domain of hRad23A, which bind to all diubiquitin chains
(linear, Lys63, and Lys48) (Figure 1A). Surface plasmon reso-
nance (SPR) experiments confirmed that the NEMO UBAN motif
bound linear diubiquitin molecules with a dissociation constant
of 1.6 mM, while binding to Lys63 or Lys48 diubiquitin molecules
was below the detection level up to around 5 mM of diubiquitin
(Figure 1B).
Structure of the CoZi Region in Complex with Linear
Diubiquitin
A challenging task in the ubiquitin field is to understand the spec-
ificity of UBD binding to particular ubiquitin chain types. Multiple
structures of UBDs in complex with monoubiquitin have beenCell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc. 1099
published (reviewed in Hurley et al., 2006), but to date no struc-
tural information exists concerning the recognition of ubiquitin
chains by UBDs. In order to investigate the binding of linear
diubiquitin to the UBAN motif, we first determined the structure
of the NEMOCoZi region alone at 2.8 A˚ resolution (Table S1).
NEMOCoZi forms a parallel coiled-coil homodimer with an overall
length of 120 A˚ (Figure 2A), showing a typical coiled-coil arrange-
ment with ‘‘a’’ and ‘‘d’’ positions occupied mostly by hydro-
phobic residues. The region between residues 288 and 290
induces a phase shift in the heptad periodicity of the coiled coil
(Figure S2), but it remains a-helical with interprotomer coiled-
coil interactions, resulting in a continuous two-helix bundle.
Pro292 induces a kink in the overall helical structure, which gives
rise to a deviation from a perfect two-fold symmetry (Figure 2B).
However, when the structure is separated into N-terminal (260 to
291) and C-terminal (293 to 330) fragments, each subdomain
displays an approximate dyad symmetry around the coiled-coil
axes, so that the Ca atoms of the two protomer subdomains
can be superimposed with RMS deviations of 0.88 A˚ and
0.92 A˚, respectively (Figure 2B). This two-fold symmetry of the
C-terminal fragment results in similar electrostatic surface
potential landscapes on both sides of the coiled coil (Figure 2C).
To gain further insight into the mechanism of NEMO binding to
linear chains, we cocrystallized NEMOCoZi with linear diubiquitin.
Depending on their position relative to the substrate, the ubiqui-
tin monomers in ubiquitin chains can be described as distal
or proximal subunits, with the proximal ubiquitin having a free
C terminus in an unattached chain. We will refer to the N- and
C-terminal ubiquitin moieties of the linear diubiquitin used in
this study as Ubdistal and Ubproximal, respectively. The structure
of NEMOCoZi in complex with linear diubiquitin was determined
at 2.7 A˚ resolution (Table S1). Each asymmetric unit of the C2
lattice contains one complex in which NEMOCoZi dimer and diu-
biquitin are present with a 1:2 stoichiometry. As expected from
the pseudo-two-fold symmetry of the homodimeric structure of
NEMOCoZi alone, the NEMO dimer accommodates two
Figure 2. Structure of the NEMOCoZi Region
(A) Overall structure of NEMOCoZi in two orthogonal views.
NEMOCoZi (residues 254–337) folds into a continuous a-helix
forming a parallel coiled coil. The two chains of NEMO are
colored in green and violet.
(B) Superposition of the two chains of NEMOCoZi colored as in
(A). The C-terminal halves of the chains are superimposed by
a 180.0 rotation with RMS deviation of 0.88 A˚ for the Ca posi-
tions of residues 293–330. Side chains of conserved residues
in the UBAN motif are shown as sticks.
(C) Two opposing views of NEMOCoZi in electrostatic potential
surface representation (blue, positive; red, negative). The view
in (C) is rotated around the vertical axis from that of (A) and (B)
by 90.
diubiquitin molecules, one on either side of
the coiled coil (Figures 3A and 3B). Both NEMO
protomers contribute to each of the diubiquitin
binding surfaces, which are comprised of
residues Glu289 to Glu320. Importantly, we have
obtained an essentially identical structure of the
NEMOCoZiCdiubiquitin complex from an independent crystal
form with a different space group (P212121).
Mapping Binding Surfaces on Ubiquitin and NEMO
Upon binding to NEMO, the two diubiquitin molecules adopt
highly similar conformations (RMS deviation of 1.17 A˚ for the
Ca positions of residues 1–146), submerging almost identical
solvent-accessible surface areas (1057 A˚2 and 1070 A˚2).
However, the distal and proximal ubiquitin moieties bind
NEMO in a remarkably divergent fashion (Figures 3C–3J). The
Ubdistal contacts NEMO using its C-terminal tail together with
the canonical hydrophobic Ile44 surface (Figures 3C and 3D),
whereas the Ubproximal employs residues located adjacent to,
but not overlapping with, the Ile44 patch (Figures 3C–3F and
S3A). The latter interaction involves residues Gln2, Phe4, Lys6,
Gly10, Thr12, Ile13, Thr14, Glu16, Glu64, and Thr66 in the
Ubproximal, which engage mainly in polar interactions with resi-
dues Arg309, Arg312, Glu313, Glu317, and Glu320 from one of
the two NEMO protomers (Figures 3C–3F, 3I, 3J, and S3A).
This mode of ubiquitin binding has not been observed for any
other UBDs studied (Hurley et al., 2006). The electron density
map for the contacting residues from NEMO UBAN, Ubproximal,
and Ubdistal, contoured at 1.0 A˚, is shown in Figures S3B and
S3C.
On the Ubdistal, the UBAN motif of NEMO recognizes the
canonical hydrophobic patch surrounding Ile44 (Figure 3C).
Although the interactions are mainly hydrophobic, salt bridges
and hydrogen bonds also contribute to binding. The electrostatic
interactions are centered on Asp304 of NEMO, making a salt
bridge with Arg72, in addition to hydrogen bonds formed with
the backbone amides of Leu73 and Arg74 of Ubdistal (Figures
3G and 3H). Notably, Leu73 and Arg74 are the only residues of
Ubdistal that bind both chains of NEMO simultaneously (Figures
3G–3J). In contrast, the last two C-terminal residues of Ubdistal,
Gly75 and Gly76, protrude away from the UBAN neighborhood
and are not involved in NEMO binding.1100 Cell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc.
In order to test whether the aforementioned linkage region
between the two ubiquitins contributes to NEMO binding, we
generated mutations in Arg72, Leu73, and Arg74 of only the
distal ubiquitin in a GST-diubiquitin. The resulting GST-Ub
(R72A,L73A,R74A)-Ub was impaired in binding to NEMO
compared to wild-type GST-diubiquitin (Figure S3D). Similarly
mutation of Gln2 in proximal ubiquitin [GST-Ub-Ub(Q2A)] also
impaired binding to NEMO in GST pull-down assays
(Figure S3D). These findings confirm that both ubiquitin moieties
in diubiquitin are essential for binding to the continuous binding
surface on the UBAN dimer.
Conformational Change in NEMOafter Ubiquitin Binding
Superimposition of the free and diubiquitin-bound structures
revealed distinct conformational changes of NEMOCoZi upon
diubiquitin binding, as indicated by an overall RMS deviation of
2.71 A˚ for the Ca atoms of the two NEMOCoZi structures (Figures
4A and 4B). Diubiquitin binding induces a slight unwinding of the
coiled coil, which is best seen in a side view of NEMOCoZi
(Figure 4C). As a result of this, the half pitch of the coiled-coil
superhelix increases by 12 A˚ in length from 67 A˚, encompassing
residues 284–328, to 79 A˚ with residues 282–334. In addition, the
aforementioned kink in NEMO caused by Pro292 is ameliorated
by the interaction of Pro292 and Glu289 in NEMO with Gly47 and
His68 of the Ubdistal, respectively. Ubiquitin binding conse-
quently causes a straightening of each of the helices of the
NEMO UBAN coiled coil (Figure 4C). These structural adjust-
ments of CoZi upon ubiquitin binding may potentially extend
throughout the molecule and may alter the interaction of
NEMO with the catalytic subunits of the IKK complex, which
could have implications for the activation of NF-kB.
Importance of NEMO Binding to Linear Chains In Vivo
The residues of the UBAN motif found in contact with ubiquitin in
the crystal structures were subsequently analyzed for their
contribution to ubiquitin binding in the context of full-length
NEMO. In agreement with our structural data, mutating the resi-
dues in the UBAN motif that electrostatically interact with either
Ubproximal (i.e., Arg309, Arg312, Glu313, Glu 317, and Glu 320) or
Ubdistal (i.e., Val293, Tyr301, Lys302, and Phe305) abolished the
binding to linear diubiquitin (Figure 5A). Similar results were ob-
tained by analysis of a bacterially expressed and purified CoZi
fragment containing the UBAN motif for binding to linear di- or
tetraubiquitin chains (Figure 5B). In contrast, the purified CoZi
fragment bound Lys63-linked ubiquitin chains only if they were
above a certain minimal length, i.e., tetraubiquitin but not diubi-
quitin. Furthermore, binding to Lys63-linked tetraubiquitin chains
was not dependent on the Arg309, Arg312, and Glu313 surface,
but was instead abrogated upon mutation of Val293/Tyr301/
Lys302 or Phe305 (Figures 5B and S4A). In order to further eval-
uate tetraubiquitin binding to NEMO, we mixed linear and Lys63
chains and performed in vitro competition assays for binding to
the CoZi fragment of NEMO. In these assays, NEMO bound
exclusively to linear chains as compared to Lys63 tetraubiquitin
chains (Figure 5C), indicating a preferential role of NEMO binding
to linear chains even in the presence of Lys63 chains. Moreover,
mutational analysis indicates that NEMO interacts with linear andLys63-linked tetraubiquitin chains in a qualitatively different
manner (Figure 5B).
The differences in binding to linear versus Lys63-linked chains,
in particular the dependence of linear chains binding to the
Ubproximal patch, allowed us to test whether binding of linear or
Lys63-linked ubiquitin chains to NEMO is essential for activation
of NF-kB in vivo. Numerous studies have indicated an essential
role of NEMO in linking TNF-a signaling pathways to activation of
NF-kB- and MAPK-related pathways (Yamamoto et al., 2006;
Matsuzawa et al., 2008). To further analyze the role of ubiquitin
binding to NEMO for NF-kB signaling in vivo, we utilized mouse
embryonic fibroblasts (MEFs) derived from NEMO knockout
mice (KO-NEMO). Similar to the wild-type MEFs, TNF-a induced
rapid phosphorylation and subsequent degradation of IkBa in
NEMO-deficient MEFs reconstituted with NEMO, but not in
NEMO-deficient MEFs expressing NEMO-V293A,Y301A,K302A
or NEMO-R309A,R312A,E313A, i.e., mutants incapable of
binding linear ubiquitin chains (Figure 5D). Moreover, compa-
rable inhibition was observed in MEF cells reconstituted with
single amino acid mutations in the distal (Phe305) patch of
NEMO and partial inhibition in the proximal (Glu313) patch of
NEMO in response to TNF-a (Figure S4B). In contrast, TNF-a
stimulated phosphorylation of p38 mitogen-activated protein
kinase (p38MAPK) and Jun N-terminal kinase (JNK) to equivalent
levels in wild-type MEFs and MEFs reconstituted with NEMO as
well as the ubiquitin-binding deficient NEMO mutants (Figure 5D).
These findings indicate that NF-kB, but not other TNF-a-stimu-
lated pathways, is impaired in the tested cells. Since TNF-a under
different conditions can mediate either cell survival or apoptosis,
presumably via changes in the level of NF-kB and JNK activities
(Chang et al., 2006), we next monitored TNF-a-induced cell
death by evaluating the cleavage of caspase-3 and changes in
chromatin condensation in MEFs (Figure 5E and 5F). TNF-a-
induced apoptosis was clearly more pronounced in NEMO
knockout MEFs and in cells reconstituted with NEMO mutants
deficient in ubiquitin binding, as compared with wild-type
MEFs or MEFs reconstituted with wild-type NEMO (Figure 5F).
In addition, we also utilized NEMO-deficient F40 B cells
(Bloor et al., 2008) to analyze a larger spectrum of stimuli and to
evaluate the effect on NF-kB signaling of our ubiquitin binding-
deficient NEMO mutants with that of previously characterized
NEMO variants, including alleles identified in patients suffering
from anhidrotic ectodermal dysplasia with immunodeficiency
(Do¨ffinger et al., 2001; Puel et al., 2004; Filipe-Santos et al.,
2006; Bloor et al., 2008). F40 cells transduced with wild-type
NEMO showed strong activation of NF-kB in response to treat-
ment with lipopolysaccharide (LPS), IL-1, CpG DNA, or PMA/ion-
omycin (Figure 6A). In contrast, cells complemented with
NEMO mutants selectively defective in binding to Ubdistal
(NEMO-V293A,Y301A,K302A, and NEMO-F305A) or Ubproximal
(NEMO-R309A,R312A,E313A), all failed to activate NF-kB,
similar to the previously described NEMO-D304N and NEMO-
E308V alleles. Thus, we can conclude that binding of both Ubdistal
and Ubproximal monomers is essential for agonist-induced NF-kB
activation. Subsequently, we introduced NEMO alleles into wild-
type B cells in order to favor the assembly of NEMO heterodimers
consisting of wild-type and mutant proteins (Figure 6B). Depend-
ing on the mutant allele, heterodimers with defects in only one ofCell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc. 1101
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the four ubiquitin interaction sites could thereby be created.
NEMO alleles deficient in binding either the proximal or the distal
ubiquitin evidently interfered with LPS-induced signaling in
a dominant-negative fashion, which implies that a defect in
even one of the four ubiquitin binding sites prevents signaling.
We suggest that, while dual anchoring of individual linear ubiqui-
tin chains by NEMO would strengthen binding, double-sided
binding of two ubiquitin chains may help to assemble supramo-
lecular signaling complexes. Such activity could explain why
NEMO serves as a hub in NF-kB signaling cascades.
DISCUSSION
NEMO Binding to Linear Ubiquitin Chains Is Important
for NF-kB Activation
The significance of ubiquitin-mediated events for the activation
of the canonical NF-kB pathway has been well established, but
the mechanism of ubiquitin-dependent signal transmission
remains less well defined. The discovery of ubiquitin-binding
modules in components of the NF-kB pathway, such as CUE
and NZF domains in TAB2/3 (Kanayama et al., 2004), UBA
domains in IAPs (Gyrd-Hansen et al., 2008; Blankenship et al.,
2009), and the UBAN motif in NEMO (Wu et al., 2006; Ea et al.,
2006; Bloor et al., 2008), have revealed mechanistic insights
into the pathway. These domains/motifs are of clear functional
importance since mutations that abrogate their binding to ubiq-
uitin chains also block activation of NF-kB by TNF-a and other
agonists, and in case of NEMO are linked to human disease (re-
viewed in Hayden and Ghosh, 2008). Based on their lower affinity
for Lys48 linked chains, the UBDs from cIAP1/2, TAB2/3, and
NEMO have been proposed to act as Lys63-selective ubiquitin
receptors. In contrast to these suggestions, here we provide
evidence for a selective binding of NEMO to linear ubiquitin
chains and demonstrate its essential contribution to the activa-
tion of NF-kB (Figures 5 and 6).
Lys63-linked chains appear to be important for receptor-
proximal events such as the recruitment and activation of the
TAK1 complex through TAB2/3, which is required for activation
of the MAPK pathways. On the other hand, linear ubiquitin chains
catalyzed by the E3 complex LUBAC affect the IKK complex via
direct binding to the UBAN motif in neighboring NEMO, which in
turn can activate the NF-kB pathway. On the basis of these data,
we propose a schematic model of NF-kB signaling in whichLys63-linked and linear ubiquitin chains have distinct functions
(Figure S6B). Current genetic evidence supports such a model.
For example, mouse hepatocytes deficient for HOIL-1, a compo-
nent of the LUBAC complex, are impaired in TNF-a-induced
activation of NF-kB, but not of the MAPK kinase pathways (Toku-
naga et al., 2009), whereas Ubc13-deficient cells, which lack
a major Lys63-specific E2 enzyme, are incapable of activating
MAPK pathways and instead show normal NF-kB activation,
after stimulation with multiple agonists (Yamamoto et al.,
2006). Yet, there appears to be a crosstalk between these path-
ways as well. For example, TAK1 kinase has been shown to
be critical for TNF-a-induced activation of both MAPK and
NF-kB pathways (Shim et al., 2005). One possibility is that
TAK1-mediated phosphorylation of IKKb may function as
a second signal required for the activation of the IKK complex
(Wang et al., 2001) or alternatively that TAK1 may be directly or
indirectly involved in regulating the LUBAC complex. The situa-
tion is even more complicated given that Lys63-dependent ubiq-
uitination and likely also linear chain formation appear to be
involved in other TNF-a-induced pathways, such as protection
from apoptosis—through both NF-kB-dependent and indepen-
dent mechanisms. Importantly, the UBAN-containing protein
ABIN-1 was recently shown to act as a ubiquitin sensor that
inhibits TNF-a-induced programmed cell death, independently
of both NF-kB and MAPK pathways (Oshima et al., 2009).
Whereas the UBAN motif of ABIN-1 was shown to interact pref-
erentially with linear diubiquitin chains, it also displayed an ability
to bind longer Lys63 and Lys48 chains with different affinities
(Wagner et al., 2008; Oshima et al., 2009).
UBAN Motif Specificity for Linear Diubiquitin Molecules
We report the crystal structure of the UBAN motif of NEMO
bound to linear diubiquitin chains and provide structural and
biochemical evidence for the specificity of this interaction versus
interactions with Lys63- or Lys48-linked diubiquitin chains
(Figure 1). Our biophysical measurements are in agreement
with reported KD values for binding of linear diubiquitin chains
(1.6 mM compared to 1.4 mM; Figure 1B) (Lo et al., 2009). Lo
et al. showed that Lys63 ubiquitin chains can bind to NEMO,
although only with an apparent KD of 131 mM (Lo et al., 2009),
which explains why we did not detect binding at the concentra-
tions used in our study (Figure 1B). We propose that the 100-fold
stronger binding of linear chains compared to Lys63-linkedFigure 3. Structure of NEMOCoZi in Complex with Diubiquitin
(A and B) Overall structure of the NEMOCoZiCdiubiquitin complex in two orthogonal views. The two chains of NEMO are colored in green and violet; Ubdistal is
shown in orange, and Ubproximal in gold.
(C and D) Open-book representation of NEMO UBAN motif recognition of distal and proximal ubiquitin moities. In (C), residues from Ubdistal (orange) and Ubproximal
(gold) that interact with the NEMO UBAN motif are labeled on the diubiquitin surface, indicating two mutually exclusive binding surfaces. (D) shows a surface
representation of NEMO UBAN motif colored according to the interaction partner, Ubdistal (orange) and Ubproximal (gold) and both (yellow). Residues involved
in the interaction are labeled.
(E and F) Open-book representations of the NEMOCoZiCdiubiquitin complex. The surfaces of linear diubiquitin (E) and NEMOCoZi (F) are colored according to their
electrostatic surface potential (blue, positive; red, negative). In (F), the bound diubiquitin is drawn as a transparent ribbon model; Ubdistal in orange and Ubproximal in
gold.
(G and I) Stereo views of the interactions of the Ubdistal (G) and Ubproximal (I) with the NEMO UBAN motif colored as in (A). Interacting residues are shown as sticks.
Hydrogen bonds and salt bridges are indicated as blue dashed lines.
(H and J) Schematic diagrams of the interactions of Ubdistal (H) and Ubproximal (J) with the NEMO UBAN motif. The two chains of NEMO are shown in green
and violet, and Ubdistal and Ubproximal in orange and gold, respectively. Dashed orange and yellow lines indicate hydrogen bonds and salt bridges, respectively.
Hydrophobic interactions are shown as dashed red lines. Residues in the NEMO UBAN domain whose mutations are found in ectodermal dysplasia (D304, E308,
and R312) are circled in red.Cell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc. 1103
chains is significant and can be explained structurally. Linear and
Lys63-linked polyubiquitin chains adopt similar ‘‘open’’ confor-
mations, and their cores including the Ile44 interaction surface
are freely rotatable with respect to each other (D. Komander,
personal communication). The major differences exist in the
linker region, where NEMO recognizes the features of a linear
chain specifically.
Bound to NEMO, the linear diubiquitin forms a more compact
structure, similar to the structure of Lys63-diubiquitin bound to
Apu3.A8 (Newton et al., 2008). The linkage environment between
Figure 4. Structural Change of NEMOCoZi upon Linear Diubiquitin
Binding
(A and B) Side views of the apo (A) and the complex (B) structures, colored as in
Figure 3, showing the length and residue numbers of the amino acids
comprising one half pitch of the coiled-coil superhelix in each case. NEMO
chains are colored in green and violet, and diubiquitins are shown in orange
(Ubdistal) and gold (Ubproximal).
(C) Side and top views of the NEMO UBAN motif in the apo and complex forms.
Residues 289 to 320, corresponding to the UBAN motif, are extracted from the
NEMOCoZi structures for drawing.1104 Cell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc.Gly76 and Met1, or Lys63 in a model with this chain type,
accounts for significant differences (Figure S5C). Notably, in
the model of a Lys63-linked chain bound to NEMO, the position
of Met1 of Ubproximal is shifted by 2 A˚ away from the NEMO UBAN
domain, as compared to the linear binding mode (Figure S5C).
This shift also moves Gln2 of the Ubproximal, affecting the interac-
tions with other critical residues, i.e., Glu16 of Ubproximal as well
as Arg309 and Arg312 of NEMO, and thus weakens Ubproximal
binding to NEMO. In accordance, mutation of Gln2 in linear
diubiquitin abolishes binding to the NEMO UBAN motif
(Figure S3D). Our data suggest that simultaneous binding of
Ubproximal and Ubdistal to the UBAN surface is only possible for
linear diubiquitin, and thus provides a potential explanation as
to how NEMO achieves linkage specificity.
Interestingly, we have observed that longer, i.e., tetrameric
but not dimeric, Lys63-linked ubiquitin can bind to our NEMO
constructs. In contrast to binding of linear diubiquitin, binding
of Lys63-linked tetraubiquitin did not require the binding surface
on NEMO for the proximal ubiquitin moiety (Figure 5B). These
observations suggest that simultaneous, parallel binding of
adjacent ubiquitin moieties of Lys63-linked chains, as seen for
linear diubiquitin in our crystal structure, is highly unlikely. On
the other hand, long Lys63-linked ubiquitin chain binding via
two canonical Ile44 patches to UBAN may favor the formation
of a trimeric complex containing only one ubiquitin chain rather
than two as demonstrated here for linear ubiquitin chains. An
attempt to model such a trimeric complex shows that it is
possible for Lys63-linked tetraubiquitin, but not diubiquitin, to
wrap around the NEMO UBAN so that the first and the fourth
ubiquitin moieties can bind the two Ubdistal binding sites
(Figure S5A).
The structure of the isolated CoZi domain of human NEMO
described by Lo et al. is equivalent to our apo structure of mouse
NEMO (Lo et al., 2009) (Figure 2). An interesting difference
between their model of the NEMO-ubiquitin complex and the
crystal structure reported here (Figure 3) regards the stoichiom-
etry of the complex, which Lo et al. report as 1:2, i.e., one diubi-
quitin molecule binds one NEMO dimer. This observation is
supported by an independent ITC study by Rittinger and
colleagues (K. Rittinger, personal communication). On the basis
of these findings, a different interaction model was proposed by
Lo et al., where one dimer wraps around NEMO UBAN and
interacts with both distal binding sites.
In two independent crystal forms for NEMO bound to linear
diubiquitin, we find 2:2 stoichiometry (one diubiquitin molecules
binding to each side of a NEMO dimer). Since NEMO dimers
have symmetrical ubiquitin binding surfaces on either side
even in the uncomplexed form (Figure 3) (Lo et al., 2009), the
apo structures do not reveal why only one chain binds in solu-
tion; the binding data suggest that that NEMO can interact
with ubiquitin chains in different modes and stoichiometries. At
this stage, and based on the current available data, it is difficult
for us to reconcile the different stoichiometries observed, and
therefore we can only speculate as to the reason for different
binding in solution versus crystals. Potentially, negative cooper-
ativity takes place in solution, disfavoring binding of the second
linear diubiquitin after a first diubiquitin has bound. Symmetric
binding of two ubiquitin chains in parallel could be favored under
higher concentrations (as in the crystallization setup) or based
on appropriate conformational positioning in larger complexes
(such as in IKK complexes). An alternative explanation is that
the structure shows the ubiquitinated form of NEMO, in which
a linear chain binds in cis and leads to a conformational change.
Since NEMO is a dimer, the ubiquitination happens on both
monomers, and two parallel chains bind simultaneously in
a 2:2 complex because of the high local concentration. Such
a model would overcome alternative binding modes that favor
interaction with a single chain only. Although further experiments
will be required to provide insight into whether the different stoi-
chiometries observed result in distinct biological outcomes
in vivo, our experiments in wild-type cells, where NEMO alleles
deficient in either the proximal or the distal ubiquitin binding
sites interfered with signaling in a dominant-negative fashion
(Figure 6B), point to a need for four functional binding sites per
NEMO dimer.
Model of Activation of the IKK Complex by Linear
Ubiquitin Chains Binding to NEMO
The IKK complex contains two protein kinases, IKKa and IKKb,
which mediate phosphorylation of IkB proteins. Most of the
IKKa and IKKb molecules are present in complex with the
regulatory component NEMO. However, despite great efforts
in the last decades, the actual mechanism of IKKb activation
has remained elusive. Our present structure, and previously
reported partial structures (Bagne´ris et al., 2008; Cordier et al.,
2008; Rushe et al., 2008), suggests that the NEMO subunits in
the IKK complex form two entwined extended helices and
function as a linear platform for the organization of the kinase
subunits on one end, and upstream activators, inhibitors, and
NEMO-modifying enzymes along the helices, until the UBZ
domain at the other end (Figure S6A).
Like many kinases, IKKb requires phosphorylation of its
activation segment for full activity, which may be achieved by
transautophosphorylation (Ha¨cker and Karin, 2006). In such
a scenario, ubiquitination or ubiquitin binding might cause
clustering and oligomerization of the IKK complex, facilitating
transactivation of the kinase subunits. A second possibility is
that IKKb is activated after conformational changes in the IKK
complex. Our observation that binding of NEMO to linear diubi-
quitin chains induces a conformational change (Figure 4C) might
support such model. The structural changes in the coiled-coil
region might translate to changes in the N-terminal part of
NEMO, causing a reorientation of the kinase domains, favoring
transautophosphorylation and activation of IKKb. A conforma-
tional change hypothesis is also consistent with results obtained
with a NEMO allele (NEMO K270A) that confers constitutive
activity to the IKK complex even when disabled to bind ubiquitin
(NEMO K270A,D304N and NEMO K270A,E308V) (Bloor et al.,
2008). Lys270 occupies a so-called ‘‘d’’ position in the coiled-
coil structure, normally occupied by hydrophobic amino acids.
The fact that CoZi K270A homodimerizes with ten times higher
affinity than wild-type CoZi reinforces the possibility that
a conformational change in NEMO K270A may cause constitu-
tive NF-kB activation.
IKKb can also be activated by its upstream kinase, TAK1,
which binds to Lys63 chains through its subunits TAB2 orTAB3 (Hayden and Ghosh, 2008). NEMO is itself a target for
ubiquitination and can be modified by at least two different ubiq-
uitin chain types, i.e., Lys63-linked and linear chains (Hayden
and Ghosh, 2008; Tokunaga et al., 2009). Lys63 chains on
NEMO may contribute to the recruitment of the TAK1/TAB2
complex, permitting TAK1-dependent phosphorylation of IKKb.
Alternatively, despite being poor binders for the UBAN domain
(Figures 1 and 5B) (Lo et al., 2009), Lys63-linked chains attached
to NEMO or other proteins may bind full-length NEMO dimers
with increased affinity and may induce kinase clustering.
However, we conclude that such binding is not sufficient for
NF-kB activation in vivo since NEMO-R309A,R312A,E313A,
despite not complementing NEMO-deficient cells, still binds
Lys63-linked ubiquitin chains. In contrast, the lack of binding
to linear chains in NEMO-R309A,R312A,E313A correlates
perfectly with its inability to support NF-kB activation, suggest-
ing that binding to linear chains is of crucial importance for
NF-kB signaling.
Linear chains attached to NEMO are formed by the recently
described LUBAC complex (Tokunaga et al., 2009). Since linear
chains on NEMO can be recognized by UBAN motifs in neigh-
boring NEMO molecules, their contribution to the regulation of
the IKK complex may involve binding to NEMO itself in either
cis or trans. Putative ubiquitination sites for LUBAC in mouse
NEMO are Lys278 and Lys302, corresponding to Lys285 and
Lys309 in the human protein. Our crystal structure and functional
experiments indicate that linear polyubiquitination at Lys302
is likely to block the UBAN motif for interaction with other ubiq-
uitin chains. On the other hand, linear polyubiquitination at
Lys278 may not affect the UBAN motif itself because Lys278
resides outside UBAN. Hence, a NEMO molecule that is linearly
polyubiquitinated at Lys278 may, in principle, still be able to bind
linear ubiquitin chains. However, the parallel nature of binding for
linear ubiquitin chains to NEMO would make such an interaction
unlikely to occur in cis, unless the ubiquitin chain is of consider-
able length. Since so far only the CoZi fragment has been tested
as an acceptor for LUBAC-mediated ubiquitination, other sites in
NEMO may exist (Tokunaga et al., 2009). The argument about
the parallel nature of binding applies to all potential ubiquitination
sites, suggesting that sites C-terminal of UBAN, for example in
the Zn finger of NEMO, would favor binding of ubiquitin chains
to the same NEMO molecule in cis, while more N-terminal sites
would favor their trans-interaction with other proteins, including
NEMO. Such interactions may lead to the reorganization and
transautophosphorylation of IKK complexes. We have also
provided evidence that all four contact sites for ubiquitin in
a CoZi dimer are required for signaling since NEMO alleles defi-
cient in binding either the proximal or the distal ubiquitin, when
expressed in wild-type cells, interfered with LPS-induced
signaling in a dominant negative fashion (Figure 6B). Signaling
through NEMO may therefore depend on its simultaneous
interaction with two linear ubiquitin chains.
Mutations in the NEMOUBANMotif Causing Ectodermal
Dysplasia and Immunodeficiency
Several studies have identified mutations in the UBAN motif in
patients suffering from anhidrotic ectodermal dysplasia and
immunodeficiency (Do¨ffinger et al., 2001; Filipe-Santos et al.,Cell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc. 1105
Figure 5. Effects of NEMO Mutations on Binding to Linear or Lys63-Linked Ubiquitin Chains and Activation of NF-kB Signaling
(A) Binding between GST-tagged linear diubiquitin and full-length NEMO. Lysates of HEK293T cells transfected with the indicated alleles of AU1-NEMO were
incubated with GST (empty) or GST-diubiquitin (diUb). GST-bound proteins were examined by immunoblotting with anti-AU1 antibody. Loadings of GST proteins
were determined by Ponceau S staining.
(B) Binding of ubiquitin chains (linear diubiquitin, linear tetraubiquitin, Lys63-linked diubiquitin, Lys63-linked tetraubiquitin) to GST (empty), GST-NEMO CoZi region
(NEMO 250–339), GST-NEMO mutants selectively defective in binding Ubdistal (NEMO-V293A,Y301A,K302A, and NEMO-F305A) or Ubproximal (NEMO-
R309A,R312A,E313A) were determined by immunoblotting with an anti-ubiquitin antibody. Loading of GST fusion proteins was determined by Ponceau S staining.1106 Cell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc.
Figure 6. Effects of NEMO Mutations on NF-kB Activation by Various Stimuli
(A) NF-kB-dependent GFP induction was measured by flow cytometry 48 hr after transduction of NEMO-deficient F40 cells carrying a stably integrated NF-kB
dependent GFP reporter gene with the indicated NEMO alleles. Cells were stimulated for the final 24 hr as indicated. NEMO levels were determined by western
blot.
(B) NF-kB-dependent GFP induction was measured by flow cytometry in GTPT3 reporter B cells carrying a stably integrated NF-kB dependent GFP reporter gene
and transduced with the indicated NEMO alleles. Cells were stimulated with LPS for the final 24 hr. NEMO levels were determined by western blot.2006). Our structure of a NEMOClinear diubiquitin complex
provides an explanation for the detrimental effect of the
D311N, E315A, and R319Q NEMO alleles in patients (corre-
sponding to D304N, E308A, and R312Q in mice) (Figure 7). The
corresponding mouse residues are also indicated in red boxes
in Figure 7, and the mouse residue numbers were used
throughout the paper unless indicated otherwise. Asp304 and
Glu308 are crucial for the binding of NEMO to diubiquitin,
mediating interactions with the side chains of Arg72 and
Arg74, respectively (Figures 3G, 3H, and S5B). A D304N muta-
tion (corresponding to human D311N) would disrupt Asp304’s
interaction with Arg72, Leu73, and Arg74 of Ubdistal, whereas
the E308A mutation will affect the electrostatic interaction with
Arg74 of Ubdistal. On the other hand, Arg312 is a critical residue
in linear diubiquitin interaction by contacting both Ubdistal
(Arg74) and Ubproximal (Gln2 and Phe4). Therefore, the R312Q(corresponding to human R319Q) mutation will not only affect
the ubiquitin binding but also the specificity for linear ubiquitin
chains. Taken together, any of these mutations will abrogate
the binding of NEMO to linear diubiquitin on both sides of the
coiled coil and will be detrimental for the activation of NF-kB.
In agreement, transduction of F40 cells with NEMO D304N or
E308V cannot restore NF-kB activation in response to LPS
stimulation, and these mutants are unable to bind ubiquitin
chains (Bloor et al., 2008).
Taken together, the structural, biochemical and functional
results in this study provide evidence that NEMO binding to
linear ubiquitin chains plays an important role in the activation
of the canonical NF-kB pathway. This function is dependent on
the UBAN motif of NEMO, a diubiquitin linear chain selective
binding module, which acts as a cellular decoder of cytokine-
induced signaling pathways.(C) Mixture of linear and Lys63-linked tetraubiquitin chains were tested for binding to GST (empty) and GST-NEMO CoZi region (NEMO 250–339) by immunoblot-
ting with an anti-ubiquitin antibody. Loading of GST fusion proteins was determined by Ponceau S staining. Four independent experiments were performed with
identical results.
(D) NEMO knockout MEF cells (KO-NEMO MEF) were reconstituted with mock, NEMO-WT, or NEMO mutants as indicated. Total cell lysates of TNF-a-stimulated
cells were analyzed for activation of NF-kB, JNK, and p38MAPK by immunoblotting with phospho-specific antibodies (p-IkBa, p-JNK, and p-p38MAPK). As a
control, cell lysates were also subjected to immunoblotting with antibodies against IkBa, JNK, p38MAPK, NEMO, and tubulin.
(E and F) Increased apoptosis in cells expressing ubiquitin binding-deficient NEMO mutants was detected by cleaved caspase-3 expression (E) and chromatin
condensation (F). Wild-type and KO-NEMO MEFs expressing the indicated NEMO alleles were stimulated by TNF-a for 6 hr after 16 hr of starvation under cyclo-
hexamide (CHX; 1 mg/ml) treatment. Lysates were blotted for the indicated antigens, and chromatin condensation was monitored after staining with DAPI. Three
independent experiments showed identical results.Cell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc. 1107
EXPERIMENTAL PROCEDURES
cDNAs, Antibodies, and Cells
M5P-AU1-muNEMO was previously described (Bloor et al., 2008). Antibodies
against NEMO were from BD and Santa Cruz. Antibodies against AU1, tubulin
and ubiquitin were from Covance, Sigma-Aldrich, and Santa Cruz, respec-
tively. Antibodies against IkBa, p-IkBa, p-p65, p65, p38, p-p38, JNK, p-JNK,
and Cleaved Caspase 3 (Asp175) were purchased from Cell Signaling, and
anti-IKKa and anti-IKKb antibodies from Imgenex. K63-linked and K48-linked
ubiquitin chains used for GST pull-down experiments were produced as
described in Komander et al. (2008). Wild-type and NEMO-deficient MEF cells
were described previously (Schmidt-Supprian et al., 2000). See the Supple-
mental Data for further details.
Protein Expression, Crystallization, and Structure Determination
For crystallization and SPR experiments, the CoZi region of mouse NEMO
(250–339) and linear diubiquitin were overexpressed as GST fusion proteins
in Escherichia coli BL21(DE3) cells. A mutant of NEMO250–339, K285N, was
used for crystallization. Crystals of the SeMet NEMO250–339 (K285N) were
grown in a condition comprising 45% (v/v) ethylene glycol, 50 mM acetate
(pH 4.0), and 0.02% (v/v) polyoxyethylene(6)decyl ether in the reservoir
solution. Statistics for data collection at BL-17A of Photon Factory, KEK,
and refinement are summarized in Table S1. For cocrystallization,
NEMO250–339 (E282A, K285A) was mixed with SeMet-substituted diubiquitin
in 1:1 molar ratio and crystallized with the sitting-drop method. Detailed
description of data collection and structure determination, as well as sur-
face plasmon resonance measurements, can be found in the Supplemental
Data.
Retroviral Transduction, DAPI Staining, and Microscopy
Full-length mouse NEMO cDNA was amplified by PCR and subcloned into
pBabe vector with BamHI/EcoRI restriction sites. Retroviral supernatants
were produced in Phoenix ecotropic packaging cells or in 293ET cells upon
cotransfection of pCL-eco. Target cells were transduced with filtered superna-
tants in the presence of polybrene. The medium was changed 6 hr after infec-
tion and cells were harvested 36–48 hr later for the further experiments. MEF
cells were plated on glass coverslips and after 24 hr fixed by 2% paraformal-
dehyde for 20 min after treatment with TNF-a. The coverslips were mounted on
10 ml aqueous mounting medium (Biomeda) containing DAPI (Molecular
Probes, 1:1000) placed on a glass holder. Images were acquired by the LSM
510 META laser scanning microscope (Zeiss).
Figure 7. A Model of Ectodermal Dysplasia Mutations in NEMO
Mutations in NEMO UBAN domain found in ectodermal dysplasia (D304, E308,
and R312) (red) are all involved in binding to linear diubiquitin at amino acids
R72, L73, and R74 in distal ubiquitin molecule (orange) or Q2, F4, and E64 in
proximal ubiquitin molecule (gold).1108 Cell 136, 1098–1109, March 20, 2009 ª2009 Elsevier Inc.ACCESSION NUMBERS
The coordinates and structure factors of the free form NEMOCoZi region and its
complex with diubiquitin in the two crystal forms, C2 and P212121, have been
deposited in the Protein Data Bank with the accession codes 3F89, 2ZVO, and
2ZVN, respectively.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and nine
figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(09)00264-5.
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